Diabetic foot ulcer (DFU) is the most typical and expensive sequela of diabetes mellitus, usually resulting in lower-extremity amputation with poor 5-year survival charges. Staphylococcus aureus is probably the most prevalent pathogen remoted from DFU, suggesting adaptation of S. aureus to the distinctive metabolic situations of diabetes.

Diabetes is a fancy metabolic dysfunction with will increase not solely in serum glucose ranges but in addition in ranges of different sugars, together with fructose, mannose, and glucose-6-phosphate (G6P). Nevertheless, the impact of metabolism of those sugars on the pathogenesis of S. aureus just isn’t totally understood.

On this research, we demonstrated that metabolism of G6P, fructose, and mannose induced larger expression of staphylococcal virulence components than did glucose metabolism, however solely G6P results had been impartial of glucose-mediated carbon catabolite repression, suggesting a physiologically related position in diabetes.

Our in vivo research additional demonstrated that G6P was extremely current in pores and skin adipose tissues of diabetic TALLYHO/JngJ mice, and subcutaneous an infection with S. aureus brought about considerably larger tissue necrosis and bacterial burden, in comparison with nondiabetic SWR/J mice.

Lastly, enhanced pathogenesis of S. aureus in diabetic TALLYHO/JngJ mice was considerably attenuated by deletion of the hexose phosphate transport (HPT) system. These outcomes recommend that G6P is a vital metabolic sign for S. aureus, enhancing the virulence in diabetes. A greater understanding of how G6P metabolism is linked to the virulence of S. aureus will result in the event of novel different therapeutics.

Sugars are important vitamins for S. aureus to outlive and proliferate inside the host. As a result of elevated serum glucose ranges are an indicator of diabetes, most research have targeted on the impact of glucose metabolism, and little or no is thought relating to the consequences of metabolism of different sugars on the pathogenesis of S. aureus in diabetes.

On this research, we demonstrated that G6P, which is very current in diabetes, can induce expression of staphylococcal virulence components that trigger extreme tissue necrosis and bacterial burden in pores and skin infections.

Our outcomes spotlight the significance of dietary management of blood sugar ranges, not solely glucose but in addition different extremely metabolizable sugars similar to G6P. A greater understanding of how activation of the HPT system is linked to the virulence of S. aureus will information growth of novel different therapeutics.

Elements Influencing Change in Serum Uric Acid after Administration of the Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin in Sufferers With Kind 2 Diabetes Mellitus

Though sodium-glucose cotransporter 2 (SGLT2) inhibitors decrease serum uric acid, their long-term impact on uric acid metabolism just isn’t properly understood. We analyzed pooled information from research whereby sufferers with sort 2 diabetes mellitus (T2DM) acquired luseogliflozin-an SGLT2 inhibitor.

Upon stratifying sufferers by baseline glycated hemoglobin (HbA1c) or serum uric acid, decrease HbA1c or larger serum uric acid stage was related to a larger discount in serum uric acid after remedy.

At week 12 of remedy, a major enhance in urinary glucose/creatinine (Cr) ratio and urinary uric acid clearance/Cr clearance ratio (CUA /CCr ratio) and a major discount in serum uric acid had been noticed.

Comparability of the subgroups of sufferers with a discount or a rise in serum uric acid confirmed that the rise subgroup had a better estimated glomerular filtration price (eGFR) at baseline, and the eGFR was considerably lowered, related to a major discount within the CUA /CCr ratio.

A number of regression evaluation confirmed that the discount in serum uric acid within the luseogliflozin group was strongly related to baseline excessive serum uric acid, low HbA1c ranges, and a rise in eGFR. Luseogliflozin was proven to scale back serum uric acid by enhancing urinary uric acid excretion in affiliation with elevated urinary glucose.

Therapy with luseogliflozin resulted in elevated serum uric acid in some sufferers, which can be as a result of lowered glomerular filtration of uric acid by way of the tubuloglomerular suggestions. SGLT2 inhibitors lowered serum uric acid desirably in sufferers with T2DM with low HbA1c and excessive serum uric acid. This text is protected by copyright. All rights reserved.

Steroid profiling and genetic variants in Chinese language ladies with gestational diabetes mellitus

Earlier research have demonstrated that steroids had been related to gestational diabetes mellitus (GDM). Nevertheless, outcomes from completely different research remained inconsistent, and solely a restricted vary of steroids had been investigated in these research.

Subsequently, we aimed to investigate complete steroid profiling in Chinese language ladies with GDM throughout third-trimester being pregnant. In 97 Chinese language pregnant ladies, we measured steroid profile utilizing a LC-MS/MS technique, and calculated product-to-precursor ratios in metabolic pathways of steroids.

Then sixteen genetic variants of genes encoding steroidogenic enzymes had been genotyped by MassARRAY system. There have been vital variations (P < 0.05) and apparent modifications (fold change <0.67 or >1.5) in steroids (testosterone, estriol, pregnenolone and dehydroepiandrosterone) and product-to-precursor ratios (E2/T and T/AD) between GDM and management teams.

Hepatic insulin resistance (HIR) is taken into account to be an impartial predictor of metabolic problems and performs an necessary position in systemic irritation, which contributes to abnormalities in heart problems (CVD) threat components.

The purpose of this research was to research the connection between HIR and new markers of cardiovascular dangers, together with leptin/adiponectin ratio (L/A), lipoprotein(a) [Lp(a)], and tumor necrosis issue alpha (TNF-α), at comparable entire physique insulin sensitivity in non-diabetic people with or with out CVD and at excessive threat of growing sort 2 diabetes.

Diabetes (Type 2) Exosome
P141-DB2 NULL
EUR 0
Diabetes (Type 1) Exosome RNA
P241-DB1 NULL
EUR 0
Diabetes (Type 2) Exosome RNA
P241-DB2 NULL
EUR 0
Custom Antibody titration by ELISA up to 2 rabbits and 1 bleed
ELISA-1 1
EUR 202
Canine C-Peptide ELISA Kit
DLR-C-Peptide-c-48T 48T
EUR 527
  • Should the Canine C-Peptide ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A competitive inhibition quantitative ELISA assay kit for detection of Canine C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Canine C-Peptide ELISA Kit
DLR-C-Peptide-c-96T 96T
EUR 688
  • Should the Canine C-Peptide ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A competitive inhibition quantitative ELISA assay kit for detection of Canine C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Canine C-Peptide ELISA Kit
RDR-C-Peptide-c-48Tests 48 Tests
EUR 557
Canine C-Peptide ELISA Kit
RDR-C-Peptide-c-96Tests 96 Tests
EUR 774
Canine C-Peptide ELISA Kit
RD-C-Peptide-c-48Tests 48 Tests
EUR 533
Canine C-Peptide ELISA Kit
RD-C-Peptide-c-96Tests 96 Tests
EUR 740
Rat Cytochrome-C (Cyt-c) protein WB +ve control
CYTC11-C 100 ul
EUR 286
Recombinant Borrelia burgdorferi Osp-C protein (OSP-C) control for Western blot
OSPC12-C 100 ul
EUR 286
FD Rapid GolgiStain™ kit - Solution C
PK401-C 250 ml
EUR 185.77
Description: Best quality products
Human Apolipoprotein C-I protein control for WB
APOC11-C 100 ul
EUR 286
Human Apolipoprotein C-II protein control for WB
APOC22-C 100 ul
EUR 286
Human Apolipoprotein C-III protein control for WB
APOC32-C 100 ul
EUR 286
Purified Human C-Reactive Protein (CRP) control for WB
CRP12-C 100 ul
EUR 286
Purified Rat C-Reactive Protein (CRP) control for WB
CRP16-C 100 ul
EUR 286
Purified Dog C-Reactive Protein (CRP) control for WB
CRP18-C 100 ul
EUR 286
Human C-Peptide ELISA Kit
DLR-C-Peptide-Hu-48T 48T
EUR 398
  • Should the Human C-Peptide ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Human C-Peptide ELISA Kit
DLR-C-Peptide-Hu-96T 96T
EUR 511
  • Should the Human C-Peptide ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Mouse C-Peptide ELISA Kit
DLR-C-Peptide-Mu-48T 48T
EUR 450
  • Should the Mouse C-Peptide ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A competitive inhibition quantitative ELISA assay kit for detection of Mouse C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Mouse C-Peptide ELISA Kit
DLR-C-Peptide-Mu-96T 96T
EUR 582
  • Should the Mouse C-Peptide ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A competitive inhibition quantitative ELISA assay kit for detection of Mouse C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Rat C-Peptide ELISA Kit
DLR-C-Peptide-Ra-48T 48T
EUR 467
  • Should the Rat C-Peptide ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rat C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Rat C-Peptide ELISA Kit
DLR-C-Peptide-Ra-96T 96T
EUR 605
  • Should the Rat C-Peptide ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rat C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Human C-Peptide ELISA Kit
RDR-C-Peptide-Hu-48Tests 48 Tests
EUR 404
Human C-Peptide ELISA Kit
RDR-C-Peptide-Hu-96Tests 96 Tests
EUR 556
Mouse C-Peptide ELISA Kit
RDR-C-Peptide-Mu-48Tests 48 Tests
EUR 465
Mouse C-Peptide ELISA Kit
RDR-C-Peptide-Mu-96Tests 96 Tests
EUR 643
Rat C-Peptide ELISA Kit
RDR-C-Peptide-Ra-48Tests 48 Tests
EUR 486
Rat C-Peptide ELISA Kit
RDR-C-Peptide-Ra-96Tests 96 Tests
EUR 672
Human C-Peptide ELISA Kit
RD-C-Peptide-Hu-48Tests 48 Tests
EUR 387
Human C-Peptide ELISA Kit
RD-C-Peptide-Hu-96Tests 96 Tests
EUR 532
Mouse C-Peptide ELISA Kit
RD-C-Peptide-Mu-48Tests 48 Tests
EUR 446
Mouse C-Peptide ELISA Kit
RD-C-Peptide-Mu-96Tests 96 Tests
EUR 615
Rat C-Peptide ELISA Kit
RD-C-Peptide-Ra-48Tests 48 Tests
EUR 465
Rat C-Peptide ELISA Kit
RD-C-Peptide-Ra-96Tests 96 Tests
EUR 643
Recombinant (E.coli) C. perfringens beta toxin protein control for western blot
CPB12-C 100 ul
EUR 286
Recombinant (E.coli) C. perfringens epsilon toxin protein control for western blot
CPE13-C 100 ul
EUR 286
Recombinant (NS0) purified Mouse C-Reactive Protein (CRP) cotnrol for Western
CRP21-C 100 ul
EUR 286
Recombinant (NS0) purified Mouse C-Reactive Protein (CRP) cotnrol for Western
CRP24-C 100 ul
EUR 286
Recombinant (E.coli) C. perfringens alpha toxin protein control for western blot
CPA11-C 100 ul
EUR 286
Human recombinant purified His-tag c-myc protein (~65 kda) control
MYC17-C 100 ul
EUR 286
Multi Fusion-Tagged recombinant Protein 52-Kda containing 16-tags (T-7, HSV, C-myc, VSV-G, Glu-Glu, V5, e-tag, Flag, S-tag, HA, KT3, E2, Au1, Au5, 6xHis-tags) for ELISA/Western
MFPM52-C 100 ul
EUR 286
Recombinant purified Circumsporozoite (CSP, P.falciparum) C-terminal (207-397 aa) His-tag protein control for Western Blot
CSPF11-C 100 ul
EUR 286
Recombinant purified his-tag-Protein (~130 kda) control for ELISA
HISP130-C 10 ug
EUR 286
c-Myc Oncoprotein; Clone 9E10.3 (Concentrate)
RA0226-C.1 0.1 ml
EUR 125
c-Myc Oncoprotein; Clone 9E10.3 (Concentrate)
RA0226-C.5 0.5 ml
EUR 300
c-Myc Oncoprotein; Clone MYC909 (Concentrate)
RA0227-C.1 0.1 ml
EUR 125
c-Myc Oncoprotein; Clone MYC909 (Concentrate)
RA0227-C.5 0.5 ml
EUR 300
Cytochrome c (Mitochondrial Marker); Clone 7H8.2C12 (Concentrate)
RA0359-C.1 0.1 ml
EUR 125
Cytochrome c (Mitochondrial Marker); Clone 7H8.2C12 (Concentrate)
RA0359-C.5 0.5 ml
EUR 300
Cytochrome c (Mitochondrial Marker); Clone CTC05 (Concentrate)
RA0360-C.1 0.1 ml
EUR 125
Cytochrome c (Mitochondrial Marker); Clone CTC05 (Concentrate)
RA0360-C.5 0.5 ml
EUR 300
Monkey IgM (Rhesus, non-immune control) for ELISA Kit, 1 ml (target range ~20-30 ug/ml)
7060-C 1 ml
EUR 286
Multi Fusion-Tagged Protein Marker containing 5 tags (His, T7, Myc, HA, VSV-G tags) Protein (Pure ~20 Kda) for ELISA/Western
MFPM20-C 100 ul
EUR 286
Tenascin C (Stromal Marker For Epithelial Malignancy); Clone T2H5 (Concentrate)
RA0135-C.1 0.1 ml
EUR 125
Tenascin C (Stromal Marker For Epithelial Malignancy); Clone T2H5 (Concentrate)
RA0135-C.5 0.5 ml
EUR 247
Cytokeratin 8/18 (Epithelial Marker); Clone C-43 & DC10 (Concentrate)
RA0388-C.1 0.1 ml
EUR 125
Cytokeratin 8/18 (Epithelial Marker); Clone C-43 & DC10 (Concentrate)
RA0388-C.5 0.5 ml
EUR 300
HER-2 / c-erbB-2 / neu / CD340; Clone HRB2/451 (Concentrate)
RA0108-C.1 0.1 ml
EUR 125
HER-2 / c-erbB-2 / neu / CD340; Clone HRB2/451 (Concentrate)
RA0108-C.5 0.5 ml
EUR 300
CD117/c-Kit (Marker for Gastrointestinal Stromal Tumors); Clone C117/370 (Concentrate)
RA0168-C.1 0.1 ml
EUR 125
CD117/c-Kit (Marker for Gastrointestinal Stromal Tumors); Clone C117/370 (Concentrate)
RA0168-C.5 0.5 ml
EUR 300
Human PSA ELISA Combo Kit (Free + Total)
PRB-5049-C 96 assays
EUR 833
S-Adenosylmethionine (SAM) and S-Adenosylhomocysteine (SAH) ELISA Combo Kit
STA-671-C 96 assays
EUR 867
Description: S-adenosylmethionine (SAM) is a substrate for methyl transfers to various biomolecules that yields S-adenosylhomocysteine (SAH). SAH is then hydrolyzed to homocysteine and adenosine, which is converted to methionine, and ultimately back to SAM. SAH can act as a methylation inhibitor, therefore the SAM/SAH ratio, or methylation potential, is important for maintaining proper methylation in the cell. Our S-Adenosylmethionine (SAM) and S-Adenosylhomocysteine (SAH) ELISA Combo Kit is designed for detection and quantitation of both SAM and SAH in plasma, serum, lysates, or biological fluid samples. This assay is a competitive ELISA where samples and an anti-SAM or anti-SAH antibody are added to a plate coated with a SAM or SAH conjugate. The sample and conjugate compete for antibody binding, which generates a reverse curve. Samples with high SAM and SAH levels will bind the majority of the antibody, which gets washed away and results in a low OD, while samples with low SAM and SAH levels will leave more antibody available to bind to the conjugate, producing a high signal.
OxiSelect Aldehyde-Induced DNA Damage ELISA Combo Kit (Ethenoadenosine / Ethenocytidine Quantitation)
STA-820-C 96 assays
EUR 798
Description: The OxiSelect Aldehyde-Induced DNA Damage ELISA Combo Kit (Ethenoadenosine / Ethenocytidine Quantitation) is a competitive ELISA kit allowing the quantitation of ethenoadenosine or ethenocytidine adducts in DNA isolated from cells or tissues. Samples and standards are added to a provided microplate preabsorbed with etheno-damaged DNA. A primary antibody is added and binds competitively to ethenoadenosine in the unknown sample or to the etheno adduct in the DNA coated on the plate. After washing a secondary antibody is added. A low signal means most of the primary antibody was bound to the unknown, indicating a high level of etheno adducts in the sample. Each combo kit can perform up to 96 assays combined for ethenoadenosine and ethenocytidine. The two targets are assayed in separate wells, but any well on the provided plate may be used for either target in any ratio (e.g. 64 wells for ethenoadenosine and 32 wells for ethenocytidine, or 48 wells for each).
OxiSelect UV-Induced DNA Damage ELISA Combo Kit (CPD / 6-4PP Quantitation)
STA-322-C 96 assays
EUR 827
Description: Our OxiSelect UV-Induced DNA Damage ELISA Combo Kit measures the formation of both CPD and 6-4PP structures in DNA isolated from cells or tissues. Standards or unknown DNA samples are first heat denatured before adsorbed onto a 96-well DNA binding plate.  The sample or standard are then probed with an anti-6-4PP or CPD antibody, followed by an HRP conjugated secondary antibody. CPD and 6-4PP structures are assayed on the same plate but in separate wells.
DIRECTPCR LYSIS REAGENT (CELL)
302-C 100 ml
EUR 207
Description: For use with cultured cells
DIRECTPCR LYSIS REAGENT (CELL)
301-C 50 ml
EUR 141
Description: For use with cultured cells
Bovine DNAse 1 Protein Western blot +ve control
DNASE11-C 100 ul
EUR 286
Recombinant (CHO) human DNAse I Protein control for WB
DNASE12-C 100 ul
EUR 286
Human spleen lysate protein control for Deoxyribonuclease II (Dnase II)
DNASE23-C 100 ul
EUR 286
DNP-labeled Molecular weight standard proteins (21, 29, 43, 68 , and 97 kda) for Western blot
DNP45-C 1 set
EUR 286
CHIKE26-R-10
APOA11-C 100 ul
EUR 286
Apolipoprotein A-Il, Human Plasma protein control for WB
APOA21-C 100 ul
EUR 286
Human Apolipoprotein B protein control for WB
APOB21-C 100 ul
EUR 286
Recombinant Human ApoE protein W. Blot +ve control
APOE11-C 100 ul
EUR 286
Recombinant Human ApoE protein W. Blot +ve control
APOE12-C 100 ul
EUR 286
Human plasma Apolipoprotein E protein control for WB
APOE13-C 100 ul
EUR 286
Human ApoE3 protein W. Blot +ve control
APOE31-C 100 ul
EUR 286
Recombinant purified Human ApoJ (Clusterin/Apolipoprotein J) protein control for WB
APOJ11-C 100 ul
EUR 286
Human Plasma Apolipoprotein J protein control for WB
APOJ13-C 100 ul
EUR 286
Purified Recombinant Human Angiopoietin 1 (Ang-1) protein WB +ve control
ANG12-C 100 ul
EUR 286
Purified (E.Coli) Recombinant Human Angiopoietin 2 (Ang-2) WB +ve control
ANG27-C 100 ul
EUR 286
Mouse Angiopoietin 3 (Ang-3) protein control for WB
ANG31-C 100 ul
EUR 286
Human Angiopoietin 4 (Ang-4) protein control for WB
ANG41-C 100 ul
EUR 286
Recombinant purified Human Angiogenin protein W. blot +ve control
ANGN12-C 100 ul
EUR 286
Human Angiostatin Kringles 1-3 purified protein W. blot +ve positive control
ANKR131-C 100 ul
EUR 286
Purified Human Angiostatin (Kringles 1-4) protein W. Blot +ve control
ANST12-C 100 ul
EUR 286
Human beta-2 glycoprotein (B2-GP or Apolipoprotein H/ApoH) W. Blot +ve control
B2GP11-C 100 ul
EUR 286
Purified Human beta-2 microglobulin (B2M) WB +ve control
B2M11-C 100 ul
EUR 286
Recombinant African Swine fever virus (ASFV) P30 protein control for western blot
ASFV11-C 100 ul
EUR 286
Purified, Porcine CABP9K (D9K/CALB3 or CABP1) protein control for WB
D9K12-C 100 ul
EUR 286
Recombinant Duffy Binding like5 (DBL5/VAR2CSA) Domain protein (45 kda) control for Western
DBL51-C 100 ul
EUR 286
Control/Blocking peptide for Mouse Neuronal migration protein doublecortin (DCX)
DCX11-C 100 ug
EUR 164
Recombinant Classical Swine Fever Virus E2 protein (CSFV-E2) control for western blot
CSFE21-C 100 ul
EUR 286
Recombinant Classical Swine Fever Virus Erns protein (CSFV-Erns) control for western blot
CSFR11-C 100 ul
EUR 286
Recombinant (E. coli) Circumsporozoite (P. vivax, CSP; 353-aa and GST) protein control for Western blot
CSPV11-C 100 ul
EUR 286
Human Liver Cathepsin B protein control for Western blot
CTHB11-C 100 ul
EUR 286
Human Liver Cathepsin D protein control for Western blot
CTHD11-C 100 ul
EUR 286
Recombinant purified mouse Liver Cathepsin D protein control for Western blot
CTHD12-C 100 ul
EUR 286
Human Liver Cathepsin G protein control for Western blot
CTHG11-C 100 ul
EUR 286
Human Liver Cathepsin H protein control for Western blot
CTHH11-C 100 ul
EUR 286
Human Liver Cathepsin L protein control for Western blot
CTHL11-C 100 ul
EUR 286
Recombinant purified Human Carboxyl Terminal Modulator Protein (CTMP) protein for Western blot
CTMP11-C 100 ul
EUR 286
Purified Cholera Toxin protein control for Western Blot
CTOX11-C 100 ul
EUR 286
Purified Cholera Toxin A subunit protein control for Western Blot
CTOX16-C 100 ul
EUR 286
Purified Cholera Toxin B subunit protein control for Western Blot
CTOX27-C 100 ul
EUR 286
Actin, Alpha-Smooth Muscle; Clone 1A4 (Concentrate)
A00002-C 1 ml
EUR 497
CD20, B-Cell; Clone L26 (Concentrate)
A00003-C 1 ml
EUR 497
Bcl-2; Clone 124 (Concentrate)
A00004-C 1 ml
EUR 497
Desmin; Clone D33 (Concentrate)
A00007-C 1 ml
EUR 497
Epithelial Membrane Antigen; Clone E29 (Concentrate)
A00008-C 1 ml
EUR 497
CD31, Endothelial Cell; Clone JC/70A (Concentrate)
A00009-C 1 ml
EUR 497
CD30, Ki-1 Antigen; Clone Ber-H2 (Concentrate)
A00016-C 1 ml
EUR 497
CD45, Leucocyte Common Antigen (LCA); Clones PD7/26 & 2B11 (Concentrate)
A00017-C 1 ml
EUR 497
Melanoma; Clone HMB45 (Concentrate)
A00019-C 1 ml
EUR 823
Neurofilament; Clone 2F11 (Concentrate)
A00020-C 1 ml
EUR 613
CD45RO, T-Cell; Clone UCHL1 Concentrate
A00024-C 1 ml
EUR 500
Cytokeratin, Multi (Acidic); Clone AE1 (Concentrate)
A00051-C 1 ml
EUR 604
Cytokeratin, Multi (Basic); Clone AE-3 (Concentrate)
A00052-C 1 ml
EUR 497
CD34, Endothelial Cell; Clone QBEnd/10 (Concentrate)
A00070-C 1 ml
EUR 497
Bcl-6; Clone PG-B6p Concentrate
A00077-C 1 ml
EUR 1610
CD43, T-Cell; Clone DF-T1 (Concentrate)
A00082-C 1 ml
EUR 497
S-100; Clone 4C4.9 (Concentrate)
A00087-C 1 ml
EUR 453
Cytokeratin 10; Clone DE-K10 (Concentrate)
A00089-C 1 ml
EUR 497
CD10, CALLA (Neutral Endopeptidase); Clone 56C6 (Concentrate)
A00091-C 1 ml
EUR 497
Estrogen Receptor; Clone 11D5 (Concentrate)
A00106-C 1 ml
EUR 519
CA19-9; Clone 121SLE (Concentrate)
A00107-C 1 ml
EUR 365
Thyroglobulin; Clone 2H11 (Concentrate)
A00108-C 1 ml
EUR 365
p53; Clone BP53-12 (Concentrate)
A00109-C 1 ml
EUR 365
CD31; Clone C31.7 (Concentrate)
A00110-C 1 ml
EUR 365
Cyclin D1; Clone DCS-6 (Concentrate)
A00111-C 1 ml
EUR 365
p40 (DeltaNp63); Polyclonal (Concentrate)
A00112-C 1 ml
EUR 437
Kappa; Clone L1C1 (Concentrate)
A00113-C 1 ml
EUR 437
Insulin; Clone 2D11-H5 (Concentrate)
A00114-C 1 ml
EUR 437
MART-1; Clone M2-7C10 (Concentrate)
A00115-C 1 ml
EUR 437
MART-1; Clone M2-9E2 (Concentrate)
A00116-C 1 ml
EUR 437
CD57 (HNK-1); Clone NK-1 (Concentrate)
A00117-C 1 ml
EUR 437
Renal Cell Carcinoma (RCC); Clone 66.4.C2 (Concentrate)
A00118-C 1 ml
EUR 437
Bcl-2; Clone 100/D5 (Concentrate)
A00119-C 1 ml
EUR 437
UchL1 (PGP9.5); Clone 31A3 (Concentrate)
A00120-C 1 ml
EUR 437
CD56; Clone 123C3 (Concentrate)
A00121-C 1 ml
EUR 365
Cytokeratin 19; Clone A53-B/A2.26 (Concentrate)
A00122-C 1 ml
EUR 365
CD45RA (LCA); Clone 158-4D3 (Concentrate)
A00123-C 1 ml
EUR 437
MUC5AC (Gastric Mucin); Clone 45M1 (Concentrate)
A00124-C 1 ml
EUR 437
p21WAF1; Clone WA-1 (Concentrate)
A00125-C 1 ml
EUR 365
CD31; Clone C31.3 (Concentrate)
A00126-C 1 ml
EUR 365
Secretory Component; Clone SC05 (Concentrate)
A00127-C 1 ml
EUR 437
Estrogen Receptor; Clone ERa078 (Concentrate)
A00128-C 1 ml
EUR 437
CD45; Clone 2B11 (Concentrate)
A00129-C 1 ml
EUR 383
CD45RB; Clone PD7/26 (Concentrate)
A00130-C 1 ml
EUR 370
Napsin A; Clones NAPSA/1238 & NAPSA/1239 (Concentrate)
A00131-C 1 ml
EUR 488
Tyrosinase; Clone T311 (Concentrate)
A00132-C 1 ml
EUR 629
MART-1; Clones M2-7C10 & M2-9E3 (Concentrate)
A00133-C 1 ml
EUR 484
Melanoma; Pan (Concentrate)
A00134-C 1 ml
EUR 676
Carcinoembryonic Antigen, Pan (CEA); Clone COL-1 (Concentrate)
A00135-C 1 ml
EUR 490
Cytokeratin 8; Clone K8/383 (Concentrate)
A00136-C 1 ml
EUR 617
Cytokeratin 6; Clone EP67 (Concentrate)
A00140-C 1 ml
EUR 617
Cytokeratin 7; Clone OV-TL12/30 (Concentrate)
A00142-C 1 ml
EUR 505
TTF-1; Clone 8G7G3/1 (Concentrate)
A00144-C 1 ml
EUR 497
CD15 / FUT4; Clone Leu-M1 (Concentrate)
A00151-C 1 ml
EUR 497
Cytokeratin, Pan; Clones AE1 & AE3 (Concentrate)
A00152-C 1 ml
EUR 497
Melanoma Associated Antigen; Clone KBA.62 (Concentrate)
A00153-C 1 ml
EUR 497
Placental Alkaline Phosphatase (PLAP); Clone ALP/870 (Concentrate)
A00154-C 1 ml
EUR 746

We searched Medline, Embase, the Cochrane Library, and gray literature sources as much as August 2021 for randomized managed trials (RCTs) that in contrast sotagliflozin with placebo or different antidiabetic brokers in sufferers with sort 2 diabetes. Our main final result was change in HbA1c from baseline.

RELATED ARTICLESMORE FROM AUTHOR

LEAVE A REPLY

Please enter your comment!
Please enter your name here